KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Staar Surgical (STAA) over the last 15 years, with Q3 2025 value amounting to $9.9 million.

  • Staar Surgical's Deferred Taxes rose 7630000.0% to $9.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 958.03%. This contributed to the annual value of $3.7 million for FY2024, which is 1306.72% up from last year.
  • Latest data reveals that Staar Surgical reported Deferred Taxes of $9.9 million as of Q3 2025, which was up 7630000.0% from -$9.6 million recorded in Q2 2025.
  • In the past 5 years, Staar Surgical's Deferred Taxes registered a high of $9.9 million during Q3 2025, and its lowest value of -$9.6 million during Q2 2025.
  • Its 5-year average for Deferred Taxes is $121666.7, with a median of -$1000.0 in 2024.
  • Over the last 5 years, Staar Surgical's Deferred Taxes had its largest YoY gain of 7630000.0% in 2025, and its largest YoY loss of 95940000.0% in 2025.
  • Staar Surgical's Deferred Taxes (Quarter) stood at -$3.1 million in 2021, then rose by 25.66% to -$2.3 million in 2022, then skyrocketed by 242.34% to $3.2 million in 2023, then increased by 13.88% to $3.7 million in 2024, then skyrocketed by 168.38% to $9.9 million in 2025.
  • Its Deferred Taxes was $9.9 million in Q3 2025, compared to -$9.6 million in Q2 2025 and -$1.0 million in Q1 2025.